These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26973885)

  • 1. Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing.
    Ando H; Lemire S; Pires DP; Lu TK
    Cell Syst; 2015 Sep; 1(3):187-196. PubMed ID: 26973885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Creation of synthetic bacterial viruses].
    Ando H
    Nihon Saikingaku Zasshi; 2018; 73(4):201-210. PubMed ID: 30487377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria.
    Kilcher S; Studer P; Muessner C; Klumpp J; Loessner MJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):567-572. PubMed ID: 29298913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing in vitro DNA assembly to engineer a synthetic T7 Nanoluc reporter phage for Escherichia coli detection.
    Pulkkinen EM; Hinkley TC; Nugen SR
    Integr Biol (Camb); 2019 Mar; 11(3):63-68. PubMed ID: 30927414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Engineering for Targeted Multidrug-Resistant
    Song J; Liu Z; Zhang Q; Liu Y; Chen Y
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of receptor-binding proteins in bacteriophages and phage tail-like bacteriocins.
    Dams D; Brøndsted L; Drulis-Kawa Z; Briers Y
    Biochem Soc Trans; 2019 Feb; 47(1):449-460. PubMed ID: 30783013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renaissance for Phage-Based Bacterial Control.
    Schwarz C; Mathieu J; Laverde Gomez JA; Yu P; Alvarez PJJ
    Environ Sci Technol; 2022 Apr; 56(8):4691-4701. PubMed ID: 34793127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel T4- and λ-based receptor binding protein family for bacteriophage therapy host range engineering.
    Magaziner SJ; Salmond GPC
    Front Microbiol; 2022; 13():1010330. PubMed ID: 36386655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy.
    Khan Mirzaei M; Nilsson AS
    PLoS One; 2015; 10(3):e0118557. PubMed ID: 25761060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of phage-derived RNA-based technologies in synthetic biology.
    Zhang W; Wu Q
    Synth Syst Biotechnol; 2020 Dec; 5(4):343-360. PubMed ID: 33083579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editing of a Specific Strain of Escherichia coli in the Mouse Gut Using Native Phages.
    Ping L; Zhuoya L; Pei J; Jingchao C; Yi L; Guosheng L; Hailei W
    Microbiol Spectr; 2022 Dec; 10(6):e0180422. PubMed ID: 36301104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Phage Host-Range and Suppressing Bacterial Resistance through Phage Tail Fiber Mutagenesis.
    Yehl K; Lemire S; Yang AC; Ando H; Mimee M; Torres MT; de la Fuente-Nunez C; Lu TK
    Cell; 2019 Oct; 179(2):459-469.e9. PubMed ID: 31585083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing protocols for extraction of bacteriophages prior to metagenomic analyses of phage communities in the human gut.
    Castro-Mejía JL; Muhammed MK; Kot W; Neve H; Franz CM; Hansen LH; Vogensen FK; Nielsen DS
    Microbiome; 2015 Nov; 3():64. PubMed ID: 26577924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of phages on two-species bacterial communities.
    Harcombe WR; Bull JJ
    Appl Environ Microbiol; 2005 Sep; 71(9):5254-9. PubMed ID: 16151111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Multiplexed Phage Genome Editing Using Recombitrons.
    Fishman CB; Crawford KD; Bhattarai-Kline S; Zhang K; González-Delgado A; Shipman SL
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trace detection of specific viable bacteria using tetracysteine-tagged bacteriophages.
    Wu L; Luan T; Yang X; Wang S; Zheng Y; Huang T; Zhu S; Yan X
    Anal Chem; 2014 Jan; 86(1):907-12. PubMed ID: 24299458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of phage cocktails in the inactivation of Enterobacter cloacae--An in vitro study in a buffer solution and in urine samples.
    Pereira S; Pereira C; Santos L; Klumpp J; Almeida A
    Virus Res; 2016 Jan; 211():199-208. PubMed ID: 26541317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia.
    Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Tao D; Ding L; Reed E; Gong J; Li QQ; Hu J
    Int J Mol Med; 2006 Feb; 17(2):347-55. PubMed ID: 16391836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage-mediated selection on microbiota of a long-lived host.
    Koskella B
    Curr Biol; 2013 Jul; 23(13):1256-60. PubMed ID: 23810533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage reporter technology for sensing and detecting microbial targets.
    Smartt AE; Ripp S
    Anal Bioanal Chem; 2011 May; 400(4):991-1007. PubMed ID: 21165607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.